Colgate-Palmolive (NYSE:CL – Get Free Report) will likely be posting its quarterly earnings results before the market opens ...
Colgate-Palmolive (NYSE:CL – Get Free Report) has been given a consensus recommendation of “Moderate Buy” by the twenty-two ...
JPMorgan analyst Andrea Teixeira lowered the firm’s price target on Colgate-Palmolive (CL) to $103 from $109 and keeps an Overweight rating on ...
Piper Sandler analyst Korinne Wolfmeyer maintained a Buy rating on Colgate-Palmolive (CL – Research Report) today. The company’s shares opened ...
Six class action complaints accuse major dental product makers of deceptively marketing products containing fluoride to young ...